During the past decade, Revmatologicka a interni ambulance conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Revmatologicka a interni ambulance" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "OCT Clinical Trials" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Revmatologicka a interni ambulance" are "Rheumatoid Arthritis" (4 trials). Many other conditions were trialed in "Revmatologicka a interni ambulance" in a lesser frequency.

Most popular intervention types in "Revmatologicka a interni ambulance" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab - GP2017" (1 trials), "Adalimumab - US licensed Humira" (1 trials), "Adalimumab 40mg q2w" (1 trials), "Etanercept" (1 trials) and "Filgotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Revmatologicka a interni ambulance" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Revmatologicka a interni ambulance". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Revmatologicka a interni ambulance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Revmatologicka a interni ambulance, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".